BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29982685)

  • 1. Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database.
    Tella SH; Kommalapati A; Yaturu S; Kebebew E
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3566-3573. PubMed ID: 29982685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
    Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C
    Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
    Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
    Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection of synchronously metastatic adrenocortical cancer.
    Dy BM; Strajina V; Cayo AK; Richards ML; Farley DR; Grant CS; Harmsen WS; Evans DB; Grubbs EG; Bible KC; Young WF; Perrier ND; Que FG; Nagorney DM; Lee JE; Thompson GB
    Ann Surg Oncol; 2015 Jan; 22(1):146-51. PubMed ID: 25092161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database.
    Canter DJ; Mallin K; Uzzo RG; Egleston BL; Simhan J; Walton J; Smaldone MC; Master VA; Bratslavsky G; Kutikov A
    Can J Urol; 2013 Oct; 20(5):6915-21. PubMed ID: 24128829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with survival in pediatric adrenocortical carcinoma: An analysis of the National Cancer Data Base (NCDB).
    Gulack BC; Rialon KL; Englum BR; Kim J; Talbot LJ; Adibe OO; Rice HE; Tracy ET
    J Pediatr Surg; 2016 Jan; 51(1):172-7. PubMed ID: 26572849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of advanced adrenocortical carcinoma: a 21-year population-based analysis.
    Tran TB; Liou D; Menon VG; Nissen NN
    Am Surg; 2013 Oct; 79(10):1115-8. PubMed ID: 24160811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
    Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
    J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
    Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
    Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
    Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
    Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
    Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management and clinical prognosis of adrenocortical carcinoma.
    Dong D; Li H; Yan W; Ji Z; Mao Q
    Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
    Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
    Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
    Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data.
    Kerkhofs TM; Verhoeven RH; Bonjer HJ; van Dijkum EJ; Vriens MR; De Vries J; Van Eijck CH; Bonsing BA; Van de Poll-Franse LV; Haak HR;
    Eur J Endocrinol; 2013 Jul; 169(1):83-9. PubMed ID: 23641018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in access to care and outcomes in patients with adrenocortical carcinoma.
    Hammad AY; Yen TWF; Carr AA; Evans DB; Wang TS
    J Surg Res; 2017 Jun; 213():138-146. PubMed ID: 28601306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis.
    Naffouje SA; Sabesan A; Hallanger-Johnson J; Kirtane K; Gonzalez RJ; Mullinax J
    J Surg Oncol; 2021 Dec; 124(8):1261-1271. PubMed ID: 34424540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.
    Baur J; Büntemeyer TO; Megerle F; Deutschbein T; Spitzweg C; Quinkler M; Nawroth P; Kroiss M; Germer CT; Fassnacht M; Steger U;
    BMC Cancer; 2017 Aug; 17(1):522. PubMed ID: 28778197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
    Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.
    Bednarski BK; Habra MA; Phan A; Milton DR; Wood C; Vauthey N; Evans DB; Katz MH; Ng CS; Perrier ND; Lee JE; Grubbs EG
    World J Surg; 2014 Jun; 38(6):1318-27. PubMed ID: 24615603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.